Page last updated: 2024-12-11

n-(p-coumaroyl)serotonin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(p-coumaroyl)serotonin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5458879
CHEMBL ID1760547
CHEBI ID175113
SCHEMBL ID471921
MeSH IDM0295845

Synonyms (42)

Synonym
(e)-n-[2-(5-hydroxy-1h-indol-3-yl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide
201301-83-9
n6-cis-p-coumaroylserotonin
CHEBI:175113
5-hydroxy-n-feruloyltryptamine
serotonin ii, n (p-coumaroyl)-
nsc-369503
tryptamine, 5-hydroxy-n-
NSC369503 ,
68573-24-0
p-coumaric acid serotonin amide
p-coumaroylserotonin
CHEMBL1760547 ,
n-p-coumaroyl serotonin
bdbm50341135
unii-iuc27q8ach
2-propenamide, n-(2-(5-hydroxy-1h-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)-, (2e)-
iuc27q8ach ,
coumaroylserotonin 98
n-coumaroyl serotonin
p-c-serotonin
4-coumaroylserotonin
2-propenamide, n-(2-(5-hydroxy-1h-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)-, (e)-
trans-n-(p-coumaroyl)serotonin
n-coumaroyl serotonin [inci]
n-[2-(5-hydroxy-1h-indol-3-yl)ethyl]-3-(4-hydroxyphenyl)-2-propenamide
n-(p-coumaroyl) serotonin
nsc 369503
(e)-n-(2-(5-hydroxy-1h-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide
WLZPAFGVOWCVMG-FPYGCLRLSA-N
SCHEMBL471921
DTXSID10173951
(2e)-n-[2-(5-hydroxy-1h-indol-3-yl)ethyl]-3-(4-hydroxyphenyl)prop-2-enamide
n-(p-coumaroyl)serotonin
n-[2-(5-hydroxy-1h-indol-3-yl)ethyl]-p-coumaramide
Q27280901
n-(2-(5-hydroxy-1h-indol-3-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide
HY-129440
n-(p-oumaroyl) serotonin
AS-81895
CS-0105540
Z3247251374
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
hydroxyindolesAny member of the class of indoles carrying at least one hydroxy group.
carboxamideAn amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
hydroxycinnamic acid serotonin amides biosynthesis017

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)8.80000.03403.987110.0000AID590195
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amine oxidase [flavin-containing] BHomo sapiens (human)EC50 (µMol)1.20001.20004.15007.1000AID1564246
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1367568Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production measured after 24 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Inhibitory effect of moschamine isolated from Carthamus tinctorius on LPS-induced inflammatory mediators via AP-1 and STAT1/3 inactivation in RAW 264.7 macrophages.
AID590194Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Synthesis and structure-activity relationships of phenylpropanoid amides of serotonin on tyrosinase inhibition.
AID1367569Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability up to 200 uM measured after 24 hrs in presence of LPS by MTT assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Inhibitory effect of moschamine isolated from Carthamus tinctorius on LPS-induced inflammatory mediators via AP-1 and STAT1/3 inactivation in RAW 264.7 macrophages.
AID652653Inhibition of COX2 at 400 uM after 5 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
N-Caffeoyl serotonin as selective COX-2 inhibitor.
AID652652Inhibition of COX1 at 400 uM after 5 mins by spectrophotometric analysis2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
N-Caffeoyl serotonin as selective COX-2 inhibitor.
AID590195Inhibition of mushroom tyrosinase after 25 mins by spectrophotometry2011Bioorganic & medicinal chemistry letters, Apr-01, Volume: 21, Issue:7
Synthesis and structure-activity relationships of phenylpropanoid amides of serotonin on tyrosinase inhibition.
AID1367591Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability up to 200 uM measured after 24 hrs in absence of LPS by MTT assay2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Inhibitory effect of moschamine isolated from Carthamus tinctorius on LPS-induced inflammatory mediators via AP-1 and STAT1/3 inactivation in RAW 264.7 macrophages.
AID1564246Inhibition of recombinant human MAOB using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition and measured after 20 mins by fluorescence spectrophotometry2019European journal of medicinal chemistry, Nov-01, Volume: 181Cinnamamide: An insight into the pharmacological advances and structure-activity relationships.
AID1367567Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced PGE2 production pretreated for 1 hr followed by LPS addition measured after 24 hrs2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Inhibitory effect of moschamine isolated from Carthamus tinctorius on LPS-induced inflammatory mediators via AP-1 and STAT1/3 inactivation in RAW 264.7 macrophages.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's7 (33.33)29.6817
2010's12 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.69 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]